Pyrrolopyrimidine compound as BTK inhibitor and use thereof

US12378253B2 · kind B2 · utility

Assignee

• ZHEJIANG LONGCHARM BIO-TECH PHARMA. CO., LTD. · CN

Inventors

• Yang Zhang · San Diego, US
• Wentao Wu · Qingdao, CN
• Kaijun GENG · Shanghai, CN
• Qiu LI · Shanghai, CN
• Jian Li · Shanghai, CN
• Shuhui CHEN · Shanghai, CN

Key dates

• Filing date: Nov 13, 2020
• Grant date: Aug 5, 2025
• Expiry date: Nov 30, 2041

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P37/02
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Disclosed are a pyrrolopyrimidine compound and a use thereof in preparing a medicine for diseases related to a BTK protein kinase inhibitor. Specially, disclosed are a compound as shown in formula (III) and a pharmaceutically acceptable salt thereof.